Guggenheim analyst Seamus Fernandez said the total addressable market for GLP-1 drugs like Ozempic and Wegovy could balloon to $150 billion to $200 billion.
In this article, we will take a look at the 13 tech stocks with biggest upside. To see more such companies, go directly to 5 Tech Stocks with Biggest Upside. Technology stocks are really keeping their rally alive this year, defying all expectations. The AI-led rally that started in 2023 shows no signs of abating. […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) Director Bridgette P. Heller sold 600 shares of DexCom stock in a transaction that occurred on Tuesday, September 12th. The stock was sold at an average price of $106.56, for a total transaction of $63,936.00. Following the completion of the transaction, the director now directly owns 23,731 shares […]
AMF Tjanstepension AB trimmed its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.7% in the second quarter, HoldingsChannel reports. The firm owned 107,530 shares of the medical device company’s stock after selling 7,713 shares during the period. AMF Tjanstepension AB’s holdings in DexCom were worth $13,819,000 as of its most recent SEC filing. […]
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood sugar monitor, signaling a significant move in the company's health technology endeavors.